Acute upper respiratory tract infection in children
Conditions
Interventions
Control group:The control group was treated by clinical standard (1) general treatment
2) Anti-infection therapy
3) Symptomatic treatment: antipyretic or sedation.
experimental group:The experimental group was treated with clinical standard treatment and children's Qingyan antipyretic oral liquid. See the instructions for usage.
Sponsors
ShaoXing Central hospital
Eligibility
Sex/Gender
All
Age
1 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1) Meet the diagnostic criteria of western medicine for children with acute upper respiratory tract infection; 2) Meet the diagnostic criteria of common cold with wind-heat syndrome in traditional Chinese medicine; 3) Age 1 ~ 14 years old regardless of sex; 4) The course of the disease is within 48 hours and the highest axillary temperature is =37.3? and < 39? within 24 hours before entering the group which is generally good; 5) The informed consent process conforms to the regulations and the legal guardian signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Children with lower respiratory tract infections such as bronchiolitis bronchitis and pneumonia; 2) the total number of white blood cells is more than 1.5 times the upper limit of reference value and neutrophils are more than 75%; 3) Children who used Chinese and western medicines to treat this disease within 48 hours before joining the group (which may affect the judgment of curative effect); 4) Children with a history of epilepsy or febrile convulsions or recurrent respiratory infections; 5) Children who are allergic to experimental drugs or allergic constitution (allergic to two or more foods or drugs); 6) children with severe malnutrition and rickets or children with other serious systemic diseases such as cardiovascular brain liver kidney and hematopoietic system; 7) The child has symptoms of infection and poisoning serious diseases serious bacterial infections and other serious complications; 8) Children who have participated in other clinical observations in the past 2 months; 9) Children who the researcher thinks are not suitable for clinical observation. Anyone who meets any of the above items should be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete antipyretic time; | — |
Secondary
| Measure | Time frame |
|---|---|
| healing time;Time of disappearance of single symptom;Days and utilization rate of antipyretic and analgesic drugs;Days of antibiotic use and utilization rate;Changes of TCM syndrome integral; | — |
Countries
The People's Republic of China
Contacts
Public ContactXiaojuan Xu
ShaoXing Central hospital
Outcome results
None listed